P V Sergeev1, O V Panov, S V Egorova, E N Bolotova, N L Shimanovskii, T A Akhadov, N K Sviridov. Show Affiliations » 1. Moscow State Medical University.
Abstract
Mesh： See more » AnimalsContrast Media/administration & dosageContrast Media/adverse effectsContrast Media/chemistryDrug Administration RoutesGadolinium/administration & dosageGadolinium/adverse effectsGadolinium/chemistryGadolinium DTPAHeterocyclic Compounds/administration & dosageHeterocyclic Compounds/adverse effectsHeterocyclic Compounds/chemistryHumansMagnetic Resonance Imaging/methodsMeglumine/administration & dosageMeglumine/adverse effectsMeglumine/chemistryOrganometallic Compounds/administration & dosageOrganometallic Compounds/adverse effectsOrganometallic Compounds/chemistryPentetic Acid/administration & dosagePentetic Acid/adverse effectsPentetic Acid/analogs & derivativesPentetic Acid/chemistrySafety
Substances： See more » Contrast MediaHeterocyclic CompoundsOrganometallic CompoundsgadoteridolMegluminePentetic AcidgadodiamideGadoliniumGadolinium DTPAgadoterate meglumine
Year: 1997 PMID： 9133071
Source DB: PubMed Journal: Vestn Rentgenol Radiol ISSN： 0042-4676